Publications by authors named "Ana Pereiro"

This work unfolds functionalized ABSs composed of FILs ([CCIm][CFSO] and [N1112(OH)][CFSO]), mere fluoro-containing ILs ([CCIm][CFSO] and [CCIm][CFSO]), known globular protein stabilizers (sucrose and [N1112(OH)][CFSO]), low-molecular-weight carbohydrate (glucose), and even high-charge density salt (KPO). The ternary phase diagrams were determined, stressing that FILs highly increased the ability for ABS formation. The functionalized ABSs (FILs vs.

View Article and Find Full Text PDF

Interferon alpha-2b (IFN-α2b) is an essential cytokine widely used in the treatment of chronic hepatitis C and hairy cell leukemia, and serum albumin is the most abundant plasma protein with numerous physiological functions. Effective single-step aqueous biphasic system (ABS) extraction for the simultaneous purification of IFN-α2b and BSA (serum albumin protein) was developed in this work. Effects of the ionic liquid (IL)-based ABS functionalization, fluorinated ILs (FILs; [C​2C​1Im][C​4F​9SO​3] and [N​1112(OH)][C​4F​9SO​3]) vs.

View Article and Find Full Text PDF

Proteins are inherently unstable, which limits their use as therapeutic agents. However, the use of biocompatible cosolvents or surfactants can help to circumvent this problem through the stabilization of intramolecular and solvent-mediated interactions. Ionic liquids (ILs) have been known to act as cosolvents or surface-active compounds.

View Article and Find Full Text PDF

The research on porous materials for the selective capture of fluorinated gases (F-gases) is key to reduce their emissions. Here, the adsorption of difluoromethane (R-32), pentafluoroethane (R-125), and 1,1,1,2-tetrafluoroethane (R-134a) is studied in four metal-organic frameworks (MOFs: Cu-benzene-1,3,5-tricarboxylate, zeolitic imidazolate framework-8, MOF-177, and MIL-53(Al)) and in one zeolite (ZSM-5) with the aim to develop technologies for the efficient capture and separation of high global warming potential blends containing these gases. Single-component sorption equilibria of the pure gases are measured at three temperatures (283.

View Article and Find Full Text PDF
Article Synopsis
  • - Gelatin is a widely used biopolymer in medicine because it's safe and doesn't trigger inflammation, and it can form Ionogels with ionic liquids (ILs) as cosolvents for better drug delivery.
  • - The study focuses on using a specific IL, 1-ethyl-3-methylpyridinium perfluorobutanesulfonate (FIL), with fish gelatin to enhance the solubility of drugs like Doxorubicin while maintaining the mechanical and nanostructural properties of the material.
  • - Controlled release mechanisms of Doxorubicin and Mithramycin from different Ionogel formulations were compared to traditional gelatin hydrogels, highlighting the importance of structural design for
View Article and Find Full Text PDF

Interferon-alpha 2b (IFN-α 2b) is a therapeutic protein used for the treatment of cancer, viral infections, and auto-immune diseases. Its application is hindered by a low bioavailability and instability in the bloodstream, and the search for new strategies for a target delivery and stabilization of IFN-α 2b to improve its therapeutic efficacy is crucial. Fluorinated ionic liquids (FILs) are promising biomaterials that: (i) can form self-assembled structures; (ii) have complete miscibility in water; and (iii) can be designed to have reduced toxicity.

View Article and Find Full Text PDF

In recent years, the fight against climate change and the mitigation of the impact of fluorinated gases (F-gases) on the atmosphere is a global concern. Development of technologies that help to efficiently separate and recycle hydrofluorocarbons (HFCs) at the end of the refrigeration and air conditioning equipment life is a priority. The technological development is important to stimulate the F-gas capture, specifically difluoromethane (R-32) and 1,1,1,2-tetrafluoroethane (R-134a), due to their high global warming potential.

View Article and Find Full Text PDF

Phenylketonuria (PKU) is an autosomal recessive disease caused by deficient activity of human phenylalanine hydroxylase (hPAH), which can lead to neurologic impairments in untreated patients. Although some therapies are already available for PKU, these are not without drawbacks. Enzyme-replacement therapy through the delivery of functional hPAH could be a promising strategy.

View Article and Find Full Text PDF

Background: passive immunotherapy is a therapeutic alternative for patients with COVID-19. Equine polyclonal antibodies (EpAbs) could represent a source of scalable neutralizing antibodies against SARS-CoV-2.

Methods: we conducted a double-blind, randomized, placebo-controlled trial to assess efficacy and safety of EpAbs (INM005) in hospitalized adult patients with moderate and severe COVID-19 pneumonia in 19 hospitals of Argentina.

View Article and Find Full Text PDF

In this work, polymeric membranes functionalized with ionic liquids (ILs) and exfoliated graphene nanoplatelets (xGnP) were developed and characterized. These membranes based on graphene ionanofluids (IoNFs) are promising materials for gas separation. The stability of the selected IoNFs in the polymer membranes was determined by thermogravimetric analysis (TGA).

View Article and Find Full Text PDF

Membrane technology can play a very influential role in the separation of the constituents of HFC refrigerant gas mixtures, which usually exhibit azeotropic or near-azeotropic behavior, with the goal of promoting the reuse of value-added compounds in the manufacture of new low-global warming potential (GWP) refrigerant mixtures that abide by the current F-gases regulations. In this context, the selective recovery of difluorometane (R32, GWP = 677) from the commercial blend R410A (GWP = 1924), an equimass mixture of R32 and pentafluoroethane (R125, GWP = 3170), is sought. To that end, this work explores for the first time the separation performance of novel mixed-matrix membranes (MMMs) functionalized with ioNanofluids (IoNFs) consisting in a stable suspension of exfoliated graphene nanoplatelets (xGnP) into a fluorinated ionic liquid (FIL), 1-ethyl-3-methylpyridinium perfluorobutanesulfonate ([CCpy][CFSO]).

View Article and Find Full Text PDF

In drug discovery and drug development, it is estimated that around 40% of commercialized and 90% of under-study drugs have inadequate pharmaceutical properties, severely impairing its therapeutic efficacy. Thus, there is a strong demand to find strategies to enhance the delivery of such drugs. Ionic liquids are a novel class of liquids composed of a combination of organic salts that are of particular interest alone or in combination with drug delivery systems.

View Article and Find Full Text PDF

The environmental impact of fluorinated gases (F-gases) necessitates the development of green technologies to mitigate them. Fluorinated ionic liquids (FIL/ILs) emerged as an alternative absorbent due to their unique and exceptional properties. In this work, a COSMO-based/Aspen Plus methodology was used to evaluate the performance of FIL/ILs as absorbents in the process scale of two F-gases: 1,1,1,2-tetrafluoroethane (R-134a) and difluoromethane (R-32).

View Article and Find Full Text PDF

Background: Chagas Disease is a neglected tropical disease caused by the protozoan , with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread.

View Article and Find Full Text PDF

Chagas disease (CD) affects over six million people and is a leading cause of heart failure in the Americas. Few are able to access diagnosis and treatment for CD, resulting in a missed opportunity to prevent morbimortality. Integration of testing and treatment with the primary healthcare level is a key step in ensuring affected people receive timely antitrypansomal therapy, which increasing evidence shows can prevent chronic complications from the disease and halt congenital transmission.

View Article and Find Full Text PDF

Background: On an absolute basis, Argentina is the country with the largest affected population with Chagas Disease (ChD). This constitutes a significant public health issue. As a consequence of Argentina's migratory patterns, there has been a significant increase of affected population in urban centers.

View Article and Find Full Text PDF

This work highlights unexpected, not so well known responses of ionic liquids and ionic liquid-containing systems, which are reported in a collective manner, as a short review. Examples include: (i) Minima in the temperature dependence of the isobaric thermal expansion coefficient of some ILs; (ii) Viscosity Minima in binary mixtures of IL + Molecular solvents; (iii) Anomalies in the surface tension within a family of ILs; (iv) The constancy among IL substitution of C/V at and around room temperature; (v) ILs as glass forming liquids; (vi) Alternate odd-even side alkyl chain length effects; (vii) Absolute negative pressures in ILs and IL-containing systems; (viii) Reversed-charged ionic liquid pairs; (ix) LCST immiscibility behavior in IL + solvent systems.

View Article and Find Full Text PDF

This study evaluated and compared follow-up and adverse drug reaction (ADR) reporting for Chagas disease (CD) patients treated with benznidazole (BZN) by two health teams with different levels of experience, using medical records for 204 patients participating in the first year of a scaled-up public health program for CD case detection and treatment conducted at all 46 primary health care centers in La Plata district, Buenos Aires, Argentina, in 2014. Both teams were experienced in CD patient management and trained in BZN administration, and included senior physicians, but one team had no experience in administering BZN while the other team had three years of experience due to their participation in the program's pilot project. Patients with positive serology for CD were treated with 5 mg/kg/day of BZN for 60 days.

View Article and Find Full Text PDF

Fluorinated ionic liquids (FILs) are a unique family of ionic liquids with remarkable properties, including the formation of three nano-segregated domains, which are very attractive for several emerging applications. However, the amount of available experimental data to fully characterize them is very scarce. We propose a systematic methodology to build FIL transferable molecular models within the soft-SAFT framework to describe the behaviour of FILs and their mixtures.

View Article and Find Full Text PDF

The use of fluorinated ionic liquids (FILs) as novel materials in biological and pharmaceutical applications is an emerging research field. The knowledge of their cytotoxicity and that of 1-octanol/water partition coefficients are essential to assess their environmental risks, to estimate their toxicity and activity, or the hydrophilic/lipophilic balance, as well as to explore their properties as solvents in extraction processes or for successful drug design. The study of the cytotoxicity in four different human cell lines and the experimental measurement of the partition coefficient between 1-octanol and water (P), using the slow-stirring method, were carried out for several FILs.

View Article and Find Full Text PDF

We demonstrate that fluorinated ionic liquids reduce the impact of the addition of water upon the ionic liquid's H-bond acceptance ability. This is a key factor to obtain functionalized materials to be used e.g.

View Article and Find Full Text PDF

In this study, the effect of chemical surface functionalization through oxidation of exfoliated graphite nanoplatelets in the transport properties of their aqueous nanofluids has been analyzed. With this objective, thermal conductivity and viscoelastic properties have been determined for original and oxidized nanoplatelets. The results show that the functionalization completely changes the internal structure of the suspension, which is reflected in shifts of even orders of magnitude on viscosity, yield stress, or storage or loss moduli.

View Article and Find Full Text PDF

Since the approval of recombinant human insulin by FDA in 1982, more than 200 proteins are currently available for pharmaceutical use to treat a wide range of diseases. However, innovation is still required to develop effective approaches for drug delivery. Our aim is to investigate the potential use of fluorinated ionic liquids (FILs) as drug delivery systems (DDS) for therapeutic proteins.

View Article and Find Full Text PDF